P7C3
>97%
- Product Code: 62150
CAS:
301353-96-8
| Molecular Weight: | 474.19 g./mol | Molecular Formula: | C₂₁H₁₈Br₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
P7C3 is primarily investigated for its neuroprotective properties, showing potential in preventing neuronal cell death. It has been studied in preclinical models for treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). Additionally, P7C3 has demonstrated efficacy in promoting neurogenesis, which could aid in recovery from brain injuries or strokes. Its ability to enhance mitochondrial function further supports its therapeutic potential in conditions involving cellular energy deficits. Ongoing research explores its application in mitigating chemotherapy-induced cognitive decline and improving outcomes in traumatic brain injury.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 97-100 |
| 1 H NMR Spectrum | Consistent with structure |
| Infrared spectrum | Conforms to Structure |
| LCMS | Consistent with structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿9,990.00 |
+
-
|
| 0.050 | 10-20 days | ฿19,440.00 |
+
-
|
P7C3
P7C3 is primarily investigated for its neuroprotective properties, showing potential in preventing neuronal cell death. It has been studied in preclinical models for treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). Additionally, P7C3 has demonstrated efficacy in promoting neurogenesis, which could aid in recovery from brain injuries or strokes. Its ability to enhance mitochondrial function further supports its therapeutic potential in conditions involving cellular energy deficits. Ongoing research explores its application in mitigating chemotherapy-induced cognitive decline and improving outcomes in traumatic brain injury.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :